Bio-UV Group SA AI Stock Analysis
Want to see FR:ALTUV full AI Analyst Report?
Bio-UV Group SA (ALTUV) AI Stock Analysis
Bio-UV Group SA
(Paris:ALTUV)
The overall score is heavily pressured by extremely weak technicals and a stretched valuation, both scoring at the minimum. The stock is in a deep downtrend with severe negative momentum and a triple-digit P/E ratio. The company's financial performance is a relative bright spot, supported by strong cash generation and a healthy balance sheet, but declining revenues and low profitability prevent it from offsetting the market-based risks.
Bio-UV Group SA (ALTUV) vs. iShares MSCI France ETF (EWQ)
- Market Cap
- EUR 11.38M
- Dividend Yield
- ―
- Average Volume (3M)
- 20.66K
- Price to Earnings (P/E)
- 86.6
- Beta (1Y)
- 0.32
- Revenue Growth
- -5.75%
- EPS Growth
- -78.66%
- Country
- France
- Employees
- 143
- Sector
- Industrials
- Sector Strength
- 63
- Industry
- Industrial - Pollution & Treatment Controls
Bio-UV Group SA Business Overview & Revenue Model
Company Description
Based in Lunel, France, BIO-UV Group S.A. specializes in the conception, production, and commercialization of ultraviolet (UV) light systems for the purification of water and disinfection of surfaces. Serving both private individuals and professional...
How the Company Makes Money
Bio-UV Group SA makes money primarily by selling water treatment equipment and associated services across its target markets. Key revenue streams include: (1) Sale of UV disinfection systems and related treatment units: the company generates revenue...
Bio-UV Group SA Financial Statement Overview
Summary
Mixed financials: strong cash flow (Score 70) and a solid balance sheet (Score 65) are offset by a weak income statement (Score 32) showing declining revenue and low margins. The overall financial health is adequate but requires top-line improvement.
Income Statement
32NegativeBalance Sheet
65PositiveCash Flow
70Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 35.59M | 35.90M | 39.58M | 43.13M | 51.29M | 33.46M |
| Gross Profit | 1.46M | 2.00M | 24.09M | 25.58M | 4.71M | 1.84M |
| EBITDA | 212.97K | 1.60M | 4.18M | 4.43M | 6.38M | 3.35M |
| Net Income | 187.83K | 836.34K | 31.36K | 124.89K | 2.42M | 689.38K |
Balance Sheet | ||||||
| Total Assets | 71.98M | 69.21M | 66.09M | 71.41M | 74.08M | 81.12M |
| Cash, Cash Equivalents and Short-Term Investments | 7.75M | 10.18M | 3.87M | 2.73M | 1.98M | 10.57M |
| Total Debt | 18.44M | 20.23M | 23.99M | 28.27M | 29.15M | 30.74M |
| Total Liabilities | 30.84M | 28.68M | 33.40M | 39.19M | 41.74M | 50.43M |
| Stockholders Equity | 41.08M | 40.47M | 32.69M | 32.22M | 32.24M | 30.52M |
Cash Flow | ||||||
| Free Cash Flow | 1.82M | 3.00M | 5.00M | 4.28M | 476.03K | 571.69K |
| Operating Cash Flow | 3.33M | 4.63M | 6.90M | 6.24M | 2.70M | 3.30M |
| Investing Cash Flow | -1.53M | -1.60M | -1.87M | -1.95M | -8.95M | -20.70M |
| Financing Cash Flow | -3.05M | 3.37M | -3.73M | -3.57M | -2.50M | 15.53M |
Bio-UV Group SA Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:ALTUV, the sentiment is Negative. The current price of 0.84 is above the 20-day moving average (MA) of 0.83, below the 50-day MA of 1.03, and below the 200-day MA of 1.27, indicating a neutral trend. The MACD of -0.06 indicates Negative momentum. The RSI at 41.24 is Neutral, neither overbought nor oversold. The STOCH value of 78.55 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FR:ALTUV.
Bio-UV Group SA Peers Comparison
Overall Rating
FR:DBG68Neutral
FR:SCHP59.5Neutral
FR:VIE58Neutral- FR:ALTUV47Neutral
FR:OREGE42Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| FR:DBG | 68Neutral | EUR 1.31B | 9.91 | 11.53% | 1.58% | -2.88% | 24.77% |
| Sector * | 63Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
| FR:SCHP | 60Neutral | EUR 628.72M | 35.06 | 2.68% | 1.49% | 2.29% | -59.18% |
| FR:VIE | 58Neutral | EUR 25.10B | 20.63 | 17.55% | 4.33% | -0.13% | 12.40% |
| FR:ALTUV | 47Neutral | EUR 10.91M | 86.60 | ― | ― | -5.75% | -78.66% |
| FR:OREGE | 42Neutral | EUR 13.84M | -1.11 | 19.27% | ― | 61.30% | -6.66% |
* Industrials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| FR:ALTUV | Bio-UV Group SA | 0.84 | -0.74 | -46.77% | |
| FR:DBG | Derichebourg SA | 8.22 | 2.42 | 41.57% | |
| FR:SCHP | Seche Environnement | 80.30 | 16.99 | 26.84% | |
| FR:VIE | Veolia Environnement (UK) | 34.66 | 6.87 | 24.74% | |
| FR:OREGE | Orege SA | 0.28 | -0.01 | -4.15% | |
| FR:GPE | Groupe Pizzorno Environnement SA | 58.20 | -1.05 | -1.77% |
Bio-UV Group SA Corporate Events
Bio-UV Group boosts liquidity contract resources to support share stability
Bio-UV Group SA has increased the cash resources allocated to its liquidity contract with Invest Securities by €80,000 as of 20 October 2026, in line with French market regulator AMF rules. The move is aimed at improving the liquidity of the company’...
BIO-UV Group Cuts 2026 Revenue Guidance Amid Geopolitical Delays
BIO-UV Group has revised its 2026 revenue outlook to a range of €35 million to €39 million, down from a previous forecast of €38 million to €42 million, reflecting a 7% adjustment. The change is mainly driven by longer decision cycles among clients i...
BIO-UV Group Holds Revenue Steady, Narrows Margins but Reaffirms 2026 Growth Targets
BIO-UV Group reported first-half 2026 revenue of €20.1m, broadly flat year-on-year, as robust growth in its Solutions and Services & Aftermarket divisions offset a 13% decline in Products sales amid salesforce reorganisation and weaker French swimmin...
BIO-UV Group Details Mid-2026 Liquidity Contract Activity
BIO-UV Group reported the mid-2026 status of the liquidity contract it has entrusted to All Invest for its shares listed on Euronext Growth. As of 30 June 2026, the liquidity account held 65,162 shares and a cash balance of €77,350.38, compared with...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 17, 2026